Skip to main content
. 2022 Apr 8;5:47. doi: 10.1038/s41746-022-00590-0

Table 1.

Baseline characteristics.

C3PO1 (N = 520,868) C3PO – MI/stroke (N = 198,184)2 MI/stroke Convenience Sample (N = 340,226)2 C3PO – AF (N = 174,644)2 AF Convenience Sample (N = 501,272)2
Mean ± SD, Median (quartile 1, quartile 3), or N (%)
Age (years) 48.4 ± 17.1 57.0 ± 10.3 56.2 ± 10.4 60.9 ± 10.0 61.4 ± 10.5
Women 315,577 (60.6%) 116,448 (58.8%) 195,039 (57.3%) 106,279 (60.9%) 288,334 (57.5%)
White 389,755 (74.8%) 154,712 (78.1%) 270,002 (79.4%) 140,746 (79.6%) 422,266 (84.2%)
Black 38,104 (7.3%) 13,805 (7.0%) 21,248 (6.2%) 11,103 (6.4%) 22,787 (4.5%)
Hispanic or Latino 33,762 (6.5%) 9401 (4.7%) 15,142 (4.5%) 6804 (3.9%) 14,115 (2.8%)
Asian or Pacific Islander 21,701 (4.2%) 7807 (3.9%) 13,219 (3.9%) 6003 (3.4%) 14,329 (2.9%)
Mixed 27 (0.05%) 11 (0.06%) 24 (0.07%) 7 (0.04%) 23 (0.04%)
Other 18,774 (3.6%) 5716 (2.9%) 8937 (2.6%) 4467 (2.6%) 9023 (1.8%)
Unknown 18,745 (3.6%) 6732 (3.4%) 11,654 (3.4%) 5514 (3.2%) 18,729 (3.7%)
Height (cm) 167.4 ± 10.4 166.6 ± 10.4 167.4 ± 10.3
Weight (kg) 78.3 ± 20.3 79.4 ± 19.5 79.8 ± 19.8
Systolic blood pressure (mmHg) 123 ± 17 126 ± 17 127 ± 18 128 ± 17 130 ± 19
Diastolic blood pressure (mmHg) 75 ± 10 76 ± 10 77 ± 11
Current smoker 27,202 (5.2%) 14,720 (7.4%) 12,652 (3.7%) 14,031 (8.0%) 22,020 (4.4%)
Anti-hypertensive use 147,898 (28.4%) 77,827 (39.3%) 119,954 (35.3%) 78,219 (44.8%) 173,235 (34.6%)
Diabetes 58,159 (11.2%) 29,307 (14.8%) 43,966 (12.9%) 27,953 (16.0%) 52,180 (10.4%)
Heart failure 12,555 (2.4%) 3334 (1.9%) 16,786 (3.3%)
Myocardial infarction 17,937 (3.4%) 6641 (3.8%) 18,260 (3.6%)
Total cholesterol (g/dL) 189 ± 39 195 ± 39 194 ± 40
HDL cholesterol (g/dL) 55 ± 18 57 ± 18 57 ± 18
Follow-up, years 7.2 (2.6, 12.9) 7.3 (2.8, 11.9) 7.4 (3.5, 11.8) 6.5 (2.5, 11.1) 5.4 (2.2, 9.8)

1Values shown exclude missing data.

2Only variables relevant for each risk score (CHARGE-AF for AF, PCE for MI/stroke) are depicted.